Natera and Aveta Biomics Announce Strategic Partnership Supporting Global Phase 3 Registrational Trial of APG-157 in Head and Neck Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. GOOGL
2. NOW
3. NVDA
4. SPY
5. USO
6. AMD
7. DHR
8. TSLA
9. GM
10. SMCI

Go back to Natera and Aveta Biomics Announce Strategic Partnership Supporting Global Phase 3 Registrational Trial of APG-157 in Head and Neck Cancer
(NASDAQ: NTRA) Delayed: 264.22 --0 (-0%)
Previous Close $264.22    52 Week High $13.80 
Open $264.22    52 Week Low $6.52 
Day High $264.22    P/E N/A 
Day Low $264.22    EPS $0.00 
Volume 1,107